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Background: Postpartum hemorrhage (PPH) represents a serious problem for women and obstetricians. Because
of its association with hemorrhagic shock and predisposition to disseminated coagulopathy, it is a leading cause of
maternal deaths worldwide. Furthermore, the jeopardy of PPH is rising with the secondary form of PPH occurring
between 24 hours and 6 weeks postpartum, when women are already discharged home. The causes of this
pathology are severe inflammation (endometritis), inherited coagulation disorders, consumptive coagulopathy, and
retained products of conceptions. Others are of rare occurrence, such as vessel subinvolution (VSI) of the placental
implantation site, uterine artery pseudoaneurysm, or trauma.
Case presentation: We present a rare form of recurrent secondary postpartum hemorrhage in a woman after
uncomplicated cesarean delivery, with review of the literature linked to the management of this situation
originating in the rare local VSI in the placental implantation site, defective decidual homeostasis, and coagulopathy
confined to the uterus.
Conclusion: The placental site VSI is one of the rare causes of secondary PPH, and this situation is frequently
underdiagnosed by clinicians. The histological confirmation of dilated “clustered”-shaped myometrial arteries
partially occluded by thrombi of variable “age” together with the presence of endovascular extravillous trophoblasts
confirms the diagnosis.
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Postpartum hemorrhage (PPH) represents serious problem
for women and obstetricians. Because of its association
with hemorrhagic shock and predisposition to dissemi-
nated coagulopathy, it is a leading cause of maternal deaths
worldwide [1]. The severity of PPH is potentiated by the
fact that it is not specifically associated with the mode of
delivery (vaginal vs. cesarean section). Furthermore, the
jeopardy of PPH is rising with the secondary form of PPH
(abnormal excessive bleeding from the birth canal, mostly* Correspondence: zubor@jfmed.uniba.sk
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reproduction in any medium, provided the oruterus, occurring between 24 hours and 6 weeks postpar-
tum), when women are already discharged home.
PPH is a widely underestimated obstetric problem with
variable occurrence and severity when diagnosed. This is
caused by the lack of definitions and describing criteria
used for this condition (e.g., quantification of blood loss,
variable cutoff limits for estimated blood loss, and linkage
to the mode of delivery). In general, the incidence of PPH
is approximately 5%-20% of labors [1,2], with the highest
rates in developing countries. The WHO evidence is
showing the wide geographic variability in PPH; for ex-
ample, in Africa, it accounts for 33.9% of maternal deaths
(interval 13.3-43.6%), and in Asia, 30.8% (intercountry
interval: 5.9-48.5%). Apart from this major problem in
the “third world” countries, the rising worries are observed
recently also in developed countries like Australia,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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are showing increased incidence of PPH (from 1.9% to
2.8%) [3,4]. The causes of this trend are unknown, and
we can only hypothesize the preconditions. However,
causes can be the recent increase in the overall number
of cesarean section, pertinently repeat cesarean section or
IVF techniques with an increase in morbidly attached
placenta pathologies. In general, it is the change in
health-care management about pregnant women and
labor conditions/circumstances. However, the common
etiologies remain, such as placental abruption, trans-
verse or classical cesarean delivery, manual placental
extraction, uterine hypotony/atony, severe inflammation
(endometritis), inherited coagulation disorders, consump-
tive coagulopathy, and retained products of conceptions
[4]. Others are of sporadic occurrence and play an import-
ant role such as vessel subinvolution (VSI) of the placental
implantation site [5,6], trauma, or uterine artery pseu-
doaneurysm, where the affected vessel wall does not
allow adequate contraction and involution. Under the
physiological situation, there is spontaneous thrombi
and fibrotic closure of the utero-placental vessels in the
normal postpartum period. Involution process brings
the vessels back to the nongestational state. Failure in
this process may be associated with the transient
reorganization of the vessel thrombi and their partial
occlusion that can lead to severe profuse or intermittent
vaginal bleeding after delivery [7], with rapid cardiovas-
cular collapse necessitating sometimes urgent hysterec-
tomy [8,9]. As mentioned previously, the wicked situation
occurs when PPH is presented in its secondary form,
even if it affects only 1-2% of postnatal women. This
low incidence of secondary PPH and linkage to maternal
morbidity rather than mortality was the reason for the
little attention among obstetricians, but it is recently
gaining importance and interest with the understanding
of VSI pathology and maternal deaths because of this
condition [10]. The primary danger for patient is that
bleeding in the majority occurs between 1 and 2 weeks
after delivery [11,12] when patient is often home and
unaware that the hemorrhage is significant and potentially
life threatening.
In this paper, we present a rare form of recurrent second-
ary postpartum hemorrhage in a woman after uncompli-
cated cesarean delivery, with review of the literature linked
to the management of this situation originating in the rare
local VSI in placental implantation site, defective decidual
homeostasis, and coagulopathy confined to the uterus.
Case report
A 24-year-old nulliparous primigravida woman was re-
ferred to our department in 40 + 3 weeks’ gestation for
delivery with history of regular uterine contractions
and fetal breech presentation (cervix dilated to 6 cm,presenting part above the interspinal line). She underwent
uncomplicated cesarean section (operative technique sec.
Pfannenstiel-Geppert, uterus closed by double-layer inter-
locking separate resorbable sutures, followed by continu-
ous suture of the visceral peritoneum) because of arrest
of descent and signs of fetal intrauterine hypoxia. The
estimated blood loss was 500 ml, and a prophylactic dose
of the first-generation cephalosporin was administered
intravenously. Antenatal course was uneventful, except
untreated mild pregnancy anemia (hemoglobin (Hb):
102 g/L). Patient was discharged home on the 5th day
postpartum with Hb level of 91 g/L, normal coagulation
parameters, and a recommendation for iron supplementa-
tion and follow-up of blood count. On the 27th day post-
partum, she experienced profuse vaginal bleeding with
drop in the hemoglobin level (70 g/L), but physical and
transvaginal uterine ultrasound examinations failed to
reveal the cause (regular uterine involution, no signs of
the retained placental tissue, or a visible anomaly of the
cesarean scar). Conservative management with blood
transfusion units (total volume 670 ml) and uterotonics
(oxytocin, methylergometrine) was helpful to stabilize
the patient, and she was discharged home within 4 days.
Vaginal and cervical microbiological culture has showed
disturbed vaginal flora with bacterial colonization of spe-
cies: Escherichia coli, Corynebacterium species, Candida
species, and Streptococcus agalactiae group B. However,
recommended antibiotics therapy was not administered
because of patient carelessness. On the 43rd day after
delivery, she was readmitted with recurrent severe vaginal
bleeding (Hb 86 g/L). After initial blood transfusions
(680 ml in total), the patient underwent hysteroscopy
with curettage, showing no retained products of placental
tissue or cesarean scar dehiscence. She was discharged
home with blood count of 118 g/L, normal systemic
coagulation parameters, and the recommendation of
combined estrogen-progestin therapy (estrophem/2 mg/+
duphaston/dydrogesterone/10 mg daily) for early endo-
metrium recovery. Despite this, on the 63rd day following
delivery, the patient came back to the hospital with heavy
life-threatening vaginal bleeding, signs of hemorrhagic
shock (Hb level 61 g/L), and symptoms of hemodynamic
instability (sweaty, pale looking, hypotension 90/50 mmHg,
and tachycardia 110 b.p.m.). She underwent emergency
abdominal supravaginal hysterectomy. Macroscopic exam-
ination of the lower uterine segment showed no signs of
hysterorrhaphy dehiscence during explorative laparotomy.
Similarly, microscopic examination of the uterus and
placental implantation site did not confirm the scare
dehiscence but revealed large, dilated arteries containing
partially occluding thrombi; trophoblastic cells within
and surrounding the spiral arteries confirmed by immuno-
histochemistry; endometrial simplex hyperplasia; and infec-
tion (diffuse lymphomonocyte infiltrate) of the implantation
Figure 2 Detailed view on subinvoluted vessel with partial
obliteration by thrombi (H&E staining, magnification: ×400).
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Corynebacterium species, Candida species, and Strepto-
coccus agalactiae group B (Figures 1, 2, 3). Additionally,
microscopic sections of the blood clot attached to the
placental implantation site contained inflamed necrotizing
decidua. No retained placenta or placenta accrete was
noted on multiple sections. Moreover, the local intravascu-
lar coagulation disturbance confined to the uterus was
suggested. The postoperative recovery was uneventful, and
the patient was discharged after 11 days. One and four
months later, she came for follow-up and was healthy.
Discussion
Postpartum hemorrhage is a serious obstetrics emergency
occurring independently from the mode of delivery. The
traditional definition of PPH is based on quantification of
blood loss but has variable criteria and several limitations
across countries or obstetrics national societies. In general,
for mild PPH, a blood loss >500 ml and a severe blood
loss >1000 ml are considered after spontaneous delivery
[13] or above 1000 ml in cesarean section [3]. Regardless
of definitions used, only a visual assessment of blood loss
is inaccurate [14], and many postpartum women are
subsequently underdiagnosed/overdiagnosed for PPH.
Thus, alternative blood loss assessment is a check for a
drop in hematocrit of 10% counted before and after
delivery [15]. The bleeding after labor can occur within
24 hours (primary form of PPH) or, later, from 24 hours
after delivery until 6 weeks postpartum (secondary form)
of PPH.
During the process of physiological subinvolution, bleed-
ing from the uterus is regulated by several factors and
mechanisms, for example, myometrial contraction and
local decidual and systemic coagulation factors leading
to the minimalization of blood loss after delivery. More-
over, at the end of the third trimester, the extravillousFigure 1 Local placental site vessel subinvolution (right above)
with active bleeding (left down). (H&E staining, magnification: ×100)endovascular trophoblast (EVCT) for maternal endothelial
cells in myometrial vessels located in the placental site is
starting to be replaced. With this vascular involution,
change is playing a role also in the occlusive form of the
intima layer thickening via its fibrotic transformation, local
endarteritis, thrombotization, and regeneration of the
internal elastic lamina of the uterus vascular system.
In pathology, for example, with abnormal complement
component activity or with the presence of long-lasting
expression of apoptotic genes as Bcl-2 inhibiting apoptosis
and supporting cell survival, [16] VSI develops (luminal
partial occlusion of the uterine vessels) in the previous
placental site implantation. This would result in temporary
occlusion of the vessels (mainly spiral arteries in the
superficial myometrium at the placental implantation site)
where the newly formed thrombi undergo resorption
within a period of 2–3 weeks, which can lead to recurrentFigure 3 Lymphoid (lympho-plasmocytic) inflammatory infiltration
on myometrial and basal endometrium border (H&E staining,
magnification: ×200).
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possibility of such phenomenon is becoming more
obvious when bleeding reoccurs in regular periods. In
our case, the uterine bleeding recurred in a period of
15–20 days (27th, 43rd, and 63rd day postpartum). The
severity of bleeding can be augmented by the presence of
active inflammation (confirmed also in our case), which
may enhance through the production of proinflammatory
factors of the local tissue coagulopathy [17] and switch to
the chronicity with the development of chronic dissemi-
nated intravascular coagulation [18,19]. Such “terrain” is
predisposed to secondary PPH. The situation observed
also by our study.
To diagnose the placental site VSI with the presence of
local site inflammation and tissue coagulopathy is difficult.
The exact directed histological examination of bioptic
material from the previous placental site can be helpful.
The presence of vascular subinvolution can be confirmed
by the finding of EVCT. Unfortunately, we did not observe
this in our histological specimens that were obtained from
hysteroscopy and curettage. In this situation, we have
many other clinicians working under pressure and focused
more on finding potential myometrium scar dehiscence
and observing the condition of the endometrium (hyper-
plasia after hormonal replacement therapy). Omitting
detection of EVCT and other possible helpful markers as
immunostaining positivity for cytokeratin profile, inhibin
alpha, Mel-CAM, Bcl-2, elastin, complement components,
or human placental lactogen is a mistake as they are
enriching the information for the direct diagnosis of
VSI. Moreover, the histological evidence of VSI is also
the presence of complement cascade markers (C1q, C3d,
C4, and C9) or immunoglobulins G, A, and M [20]. How-
ever, although all of these markers can be evaluated, they
did not explain the basic molecular mechanism of placen-
tal site subinvolution. Surgical pathologist must therefore
be aware of the major histopathologic findings of VSI in
every postpartum curettage or hysterectomy specimens.
The exact pathophysiology of VSI is not known. Some
suspect an immune component leading to abnormal
interaction between the maternal uterine cells and fetal
trophoblast [5]; others, as mentioned above, altered com-
plement components activity or the presence of long-
lasting expression of apoptotic genes (e.g., Bcl-2), inhibiting
apoptosis [16]. However, after the review of the literature,
there is one specific situation that is related to secondary
postpartum hemorrhage and published in MEDLINE.
The search in this register (June 2011) under keywords
“secondary or delay or unusual cause of postpartum
hemorrhage” showed 18 papers dealing with secondary
postpartum hemorrhage where 9 papers [7,10,21-27]
reported cases of secondary PPH after cesarean section
with two major conclusions: placental site VSI or uterine
artery pseudoaneurysm. To explain how cesarean sectionenhances the higher occurrence of VSI is difficult. One
may only speculate that some mechanic (e.g., altered myo-
metrium contraction and involution, fibrotic-proliferation
in scar), immune (autoimmune and healing processes,
reaction to suturing material used, local viral or bacterial
inflammation, role of lymphomonocytic and cytokine
activity), or molecular mechanisms like overexpression
and underexpression of growth factor genes involved in
the uterine scarring process, genes modifying the decidua
replacement by regular endometrium, collagen deposition
in the vessels of wound site, platelet aggregation, factor
XIII activity, and gene expressions of pro-angiogenic and
anti-angiogenic factors and receptors at the maternal-fetal
interface are playing a role with a consequent secondary
postpartum hemorrhage [28-31].
Although the incidence of secondary postpartum hemor-
rhage after cesarean section is very low (app. 0.1%) [22],
therapeutic management is close to primary PPH and
requires coordination and multidisciplinary care, aiming
the immediate hemodynamic stabilization of the patient,
depleted blood volume, and development of coagulopathy.
Treatment usually falls into one of two options: surgical
evacuation of the uterine cavity or medical treatment [32].
Often, blood and plasma unit transfusion is required.
Speculum examination of the cervix and the lower genital
tract to exclude possible lacerations is obligatory. Further-
more, uterine ultrasound is mandatory to exclude a possi-
bility of the retained placental tissue [33]. In differential
diagnosis, it is necessary to exclude vaginal bleeding
because of the severe endometritis, retained placental
tissue, or gestational trophoblastic disease, where laboratory
findings of inflammatory markers (e.g., CRP, leucocytes),
positive blood and vaginal cultures, elevated βHCG levels,
and expert ultrasound examination [33,34] are essential for
the adequate diagnosis.
Conclusions
In conclusion, we can say that placental site VSI is one
of the rare forms of secondary PPH and is frequently
underdiagnosed by clinicians. The histological confirm-
ation of dilated and “clustered”-shaped myometrial arteries
partially occluded by thrombi of variable “age,” together
with the presence of endovascular extravillous trophoblast,
confirms the diagnosis. However, this is done mainly after
the urgent hysterectomy. Furthermore, we believe that this
type of secondary PPH is of idiopathic than of iatrogenic
cause, and our previously published [35] data prove that
there are no known predictive factors for this pathology
(e.g., clinical assessment with/without transabdominal
ultrasound). The obstetricians and caregivers are demand-
ing for an early recognition of severe forms of a secondary
PPH, thus emphasizing that VSI in the placental implant-
ation site could be beneficial for targeted therapy and may
preserve woman’s fertility.
Zubor et al. BMC Pregnancy and Childbirth 2014, 14:80 Page 5 of 5
http://www.biomedcentral.com/1471-2393/14/80Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
Competing interests
The authors report no declarations of interest.
Authors’ contributions
PZ and KD contributed equally to write up of this case report. SK and KBB were
involved in the clinical management of this patient. KK and LS were involved in
histopathological analysis. JD interpreted the data and critically revised the
manuscript. All authors have read and approved the final manuscript.
Acknowledgement
This work was supported by the ITMS no. 26220120036 project “Centre of
excellence for perinatology research II” supported by EU sources. We would
like to thank Jozef Kornan, M.D. for the personal assistance in patient
management and data collection.
Author details
1Department of Obstetrics and Gynecology, University Hospital Martin,
Kollarova 2, Martin 036 01, Slovakia. 2Department of Pathology, University
Hospital Martin, Kollarova 2, Martin 036 01, Slovakia. 3Department of
Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius
University, Kollarova 2, Martin 036 01, Slovak Republic.
Received: 26 February 2013 Accepted: 16 January 2014
Published: 21 February 2014
References
1. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM: Epidemiology of
postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet
Gynaecol 2008, 22:999–1012.
2. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF: WHO analysis of
causes of maternal death: a systematic review. Lancet 2006, 367:1066–1074.
3. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB,
Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J: Trends in
postpartum hemorrhage in high resource countries: a review and
recommendations from the International Postpartum Hemorrhage
Collaborative Group. BMC Pregnancy Childbirth 2009, 9:55.
4. Fong A, Leake J, Pan D, Ogunyemi D: Demographic, institutional and
obstetrical risk factors for postpartum haemorrhage mortality. J Obstet
Gynaecol 2010, 30:470–475.
5. Andrew AC, Bulmer JN, Wells M, Morrison L, Buckley CH: Subinvolution of
the uteroplacental arteries in the human placental bed. Histopathology
1989, 15:395–405.
6. Weydert JA, Benda JA: Subinvolution of the placental site as an anatomic
cause of postpartum uterine bleeding: a review. Arch Pathol Lab Med
1994, 130:1538–1542.
7. Al-Mehaisen L, Al-Kuran O, Amarin ZO, Matalka I, Beitawi S, Muhtaseb A:
Secondary postpartum hemorrhage following placental site vessel
subinvolution: a case report. Arch Gynecol Obstet 2008, 278:585–587.
8. Christopoulos P, Hassiakos D, Tsitoura A, Panoulis K, Papadias K, Vitoratos N:
Obstetric hysterectomy: review of cases over 16 years. J Obstet Gynaecol
2011, 31:139–141.
9. Tadesse W, Farah N, Hogan J, D’Arcy T, Kennelly M, Turner MJ: Peripartum
hysterectomy in the first decade of the 21st century. J Obstet Gynaecol
2011, 31:320–321.
10. Farley NJ, Kohlmeier RE: A death due to subinvolution of the
uteroplacental arteries. J Forensic Sci 2011, 56:803–805.
11. King PA, Duthie SJ, Dong ZG, Ma HK: Secondary postpartum
haemorrhage. Aust N Z J Obstet Gynaecol 1989, 29:394–398.
12. Hoveyda F, MacKenzie IZ: Secondary postpartum haemorrhage: incidence,
morbidity and current management. BJOG 2001, 108:927–930.
13. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP: Postpartum haemorrhage in
nulliparous women: incidence and risk factors in low and high risk women.
A Dutch population-based cohort study on standard (> or = 500 ml) andsevere (> or = 1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol
Reprod Biol 2004, 115:166–172.
14. Stafford I, Dildy GA, Clark SL, Belfort MA: Visually estimated and calculated
blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008,
199:519. e1-7.
15. Combs CA, Murphy EL, Laros RK Jr: Factors associated with postpartum
hemorrhage with vaginal birth. Obstet Gynecol 1991, 77:69–76.
16. Khong TY, Abdul Rahman H: Bcl-2 expression delays postpartum involution
of pregnancy-induced vascular changes in the human placental bed. Int J
Gynecol Pathol 1997, 16:138–142.
17. Zrubek H, Sikorski M: Local coagulation confined to the uterus and
adnexa–case description. Ginekol Pol 1999, 4(65):593–595.
18. Somashekhar M, Kadamba PS, Wakodkar M: Chronic disseminated
intravascular coagulation presenting as renal mass. J Indian Assoc Pediatr
Surg 2008, 13:144–146.
19. Cai B, Deitch EA, Ulloa L: Novel insights for systemic inflammation in
sepsis and hemorrhage. Mediators Inflamm 2010, 2010:642462.
20. Andrew A, Bulmer JN, Morrison L, Wells M, Buckley CH: Subinvolution of
the uteroplacental arteries: an immunohistochemical study. Int J Gynecol
Pathol 1993, 12:28–33.
21. Keane B: Recurrent secondary postpartum haemorrhage after lower
segment caesarean section. N Z Med J 1973, 79:256–257.
22. Shweni PM, Bishop BB, Hansen JN, Subrayen KT: Severe secondary
postpartum haemorrhage after caesarean section. S Afr Med J 1987,
72:617–619.
23. Paraskevaides E, Stuart B, Gardeil F: Secondary postpartum haemorrhage
from nondehisced lower caesarean section scar: a case for hysteroscopy.
Aust N Z J Obstet Gynaecol 1993, 33:427.
24. Pollio F, Staibano S, De Falco M, Buonocore U, De Rosa G, Di Lieto A:
Severe secondary postpartum hemorrhage 3 weeks after cesarean
section: alternative etiologies of uterine scar non-union. J Obstet Gynaecol
Res 2007, 33:360–362.
25. Lausman AY, Ellis CA, Beecroft JR, Simons M, Shapiro JL: A rare etiology of
delayed postpartum hemorrhage. J Obstet Gynaecol Can 2008, 30:239–243.
26. Samad S, Jonetzko P, Hawkins AP, Booth J, Thorpe-Beeston G, Marwood R:
An unusual cause of delayed postpartum haemorrhage following caesarean
section. Emerg Med J 2009, 26:621–622.
27. Majumdar A, Bird A: A case of recurrent secondary postpartum
haemorrhage treated by uterine artery embolisation. J Obstet Gynaecol
2010, 30:412–413.
28. Boscolo E, Bischoff J: Vasculogenesis in infantile hemangioma.
Angiogenesis 2009, 12:197–207.
29. Petitbarat M, Serazin V, Dubanchet S, Wayner R, de Mazancourt P, Chaouat G,
Lédée N: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/
fibroblast growth factor inducible-14 might regulate the effects of interleu-
kin 18 and 15 in the human endometrium. Fertil Steril 2010, 94:1141–1133.
30. Edwards AK, van den Heuvel MJ, Wessels JM, Lamarre J, Croy BA, Tayade C:
Expression of angiogenic basic fibroblast growth factor, platelet derived
growth factor, thrombospondin-1 and their receptors at the porcine
maternal-fetal interface. Reprod Biol Endocrinol 2011, 9:5.
31. Gosk-Bierska I, McBane RD, Wu Y, Mruk J, Tafur A, McLeod T, Wysokinski WE:
Platelet factor XIII gene expression and embolic propensity in atrial
fibrillation. Thromb Haemost 2011, 106:75–82.
32. Neill A, Thornton S: Secondary postpartum haemorrhage. J Obstet
Gynaecol 2002, 22:119–122.
33. Zubor P, Szunyogh N, Dokus K, Scasny P, Kajo K, Galo S, Biringer K, Krivus S,
Danko J: Application of uterotonics on the basis of regular ultrasonic
evaluation of the uterus prevents unnecessary surgical intervention in
the postpartum period. Arch Gynecol Obstet 2010, 282:261–267.
34. Mulic-Lutvica A, Eurenius K, Axelsson O: Uterine artery Doppler ultrasound
in postpartum women with retained placental tissue. Acta Obstet Gynecol
Scand 2009, 88:724–728.
35. Neill AC, Nixon RM, Thornton S: A comparison of clinical assessment with
ultrasound in the management of secondary postpartum haemorrhage.
Eur J Obstet Gynecol Reprod Biol 2002, 104:113–115.
doi:10.1186/1471-2393-14-80
Cite this article as: Zubor et al.: Recurrent secondary postpartum
hemorrhages due to placental site vessel subinvolution and local
uterine tissue coagulopathy. BMC Pregnancy and Childbirth 2014 14:80.
